Background illustration for clinical trials search

Paid Clinical Trials Minnesota

Discover 1,919 paid clinical trials in Minnesota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

for
Advanced Solid Tumors
Location: Cleveland OH, St Louis MO, Rochester MN,
Sponsor: Jacobio Pharmaceuticals Co., Ltd.

Sex: All

Age: 18+

Code: NCT06973564

Phase 1, Phase 2, Recruiting

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

for
Intracerebral Hemorrhage
Location: Boston MA, Worcester MA, Stony Brook NY, Manhasset NY,
Sponsor: Joseph Broderick, MD

Sex: All

Age: 18 - 70+

Code: NCT07227246

Phase 3, Recruiting

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

for
Atrial Fibrillation
Location: Lake Success NY, The Bronx NY, Winchester VA, Miami FL,
Sponsor: Biosense Webster, Inc.

Sex: All

Age: 22+

Code: NCT07227532

Recruiting

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

for
Stargardt Disease
Location: Jacksonville FL, Rochester MN, Bellaire TX, Dallas TX,
Sponsor: AAVantgarde Bio Srl

Sex: All

Age: 8 - 55

Code: NCT07161544

Phase 1, Phase 2, Recruiting

Transdiagnostic Cognitive Biomarkers

for
Pain, Depression
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 18+

Code: NCT04864080

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

for
Niemann-Pick Type C Disease, GM1 Gangliosidosis,
Location: Fairfax VA, Rochester MN, Minneapolis MN, Dallas TX,
Sponsor: Azafaros B.V.

Sex: All

Age: 4+

Code: NCT07054515

Phase 3, Recruiting

Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

for
Osteoarthritis Knee Pain
Location: Washington D.C. DC, Richmond VA, Altoona PA,
Sponsor: Saol Therapeutics Inc

Sex: All

Age: 40+

Code: NCT07226258

Phase 3, Recruiting

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

for
Platinum-resistant Ovarian Cancer
Location: Boston MA, New Haven CT, Fairfax VA, Sarasota FL,
Sponsor: Stemline Therapeutics, Inc.

Sex: Female

Age: 18+

Code: NCT07226427

Phase 1, Recruiting

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

for
Relapsing Remitting Multiple Sclerosis
Location: Baltimore MD, Morgantown WV, Atlanta GA, Milwaukee WI,
Sponsor: SetPoint Medical Corporation

Sex: All

Age: 22 - 60

Code: NCT06796504

Recruiting

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

for
Recurrent Solid Tumor, Recurrent Ewing Sarcoma,
Location: Montreal, Washington D.C. DC, Toronto, Atlanta GA,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 1 - 30

Code: NCT04901702

Phase 1, Phase 2, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for
Cervical Cancer
Location: Halifax, Providence RI, Quebec, Sherbrooke, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07216703

Phase 3, Recruiting

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

for
Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia
Location: Burlington MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04840602

Phase 2, Recruiting

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

for
Locally Advanced Urothelial Carcinoma,
Location: Worcester MA, Saint Johnsbury VT, Lebanon NH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06524544

Phase 3, Recruiting

A Study of Mayo Clinic CV Research Heart & Voice Study

for
Cardiovascular Diseases
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07224685

Recruiting

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Durham NC, Houston NC, St. Petersburg FL, Ann Arbor MI,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06906627

Recruiting

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

for
Heart Failure - NYHA II - IV
Location: Fall River MA, Flushing NY, New York NY, Albany NY,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07069738

Recruiting

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Providence RI, Hartford CT, Lebanon NH, Commack NY,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07409272

Phase 3, Recruiting

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Durham NC, St. Petersburg FL, Ann Arbor MI,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06906640

Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

for
HNSCC, ESCC, Esophageal Adenocarcinoma, Gastric Adenocarcinoma,
Location: Boston MA, New Haven CT, Hackensack NJ, Philadelphia PA,
Sponsor: Normunity AccelCo, Inc.

Sex: All

Age: 18+

Code: NCT07182149

Phase 1, Recruiting

A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT)

for
Hereditary Hemorrhagic Telangiectasia
Location: Indianapolis IN, Chicago IL, St Louis MO, Rochester MN
Sponsor: Vaderis Therapeutics AG

Sex: All

Age: 18+

Code: NCT07743671

Phase 3, Recruiting

Popular cities in Minnesota

Minnesota offers a strong healthcare network and renowned medical research institutions, making it a prominent hub for a wide range of clinical trials. Leading organizations such as the Mayo Clinic, University of Minnesota Medical School, and Hennepin Healthcare are at the forefront of cutting-edge research.

These institutions are recognized globally for their contributions to medical advancements, placing Minnesota as a key player in clinical trials across various medical fields, from cancer and cardiovascular research to neurological and rare diseases.

Why choose Minnesota for clinical trials?

For people considering participation in a clinical trial, Minnesota provides distinct advantages. The state is home to a diverse and engaged population, which enriches the pool of participants and enhances the relevance of research findings. Minnesota is also renowned for its innovative healthcare landscape, highlighted by institutions that are at the forefront of medical research and technological advancements.

By choosing to participate in a clinical trial in Minnesota, participants can contribute to significant medical research while benefiting from a well-established and collaborative clinical research environment that prioritizes patient safety and care.

Common conditions studied in Minnesota

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Minnesota